stella
beta
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone — Stella
Recruiting
Back to High Risk Prostate Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
University of California, San Francisco, San Francisco, California
View full record on ClinicalTrials.gov